EFFECTS OF RESISTANCE TRAINING IN ELDERLY

• Sponsor: Daysi Tobelem (Other)
• Overall Status: Unknown status
• CT.gov ID: NCT03320005
• Collaborator: (none)
• Enrollment: 25
• Arms: 2
• Anticipated Duration (Months): 12

Study Details

Study Description

Brief Summary

This comes from a non-randomized clinical trial, which aims to check on elderly women the effects of a program of resistance training (TR) in physical performance, in respiratory functional capacity, on health and quality of life.

Condition or Disease	Intervention/Treatment	Phase
Aging Disorder	Other: Resistance training group	N/A

Detailed Description

Will be measured the strength of the respiratory muscles (Mip and Mep), peak expiratory flow (Peak-Flow), thoracic movements and abdominal movements, distance traveled in Incremental Shuttle Walk Test, grip strength manual, pulmonary leukocytes, biochemical parameters and indicators of quality of life and physical activity through the WHOQOL-old and IPAQ-short. The data will be tested against the distribution of the Gauss curve, by the shapiro-wilk test and, if they have a normal distribution (parametric) are expressed as mean and standard deviation, if not submit normal (non parametric) distribution will be expressed as median or range interquartílico. The first chance to compare the evolution of the group studied, will be applied to two-way ANOVA. If the distribution is abnormal, it will apply Mann-Whitney test. The multiple regression test will be used to compare the Mip and Mep with variables with the Peak-Flow, Thoracoabdominal mobility, distance traveled, immune competence, physical fitness and quality of life in the groups studied.

Study Design

• Study Type: Interventional
• Anticipated Enrollment: 25 participants
• Allocation: Non-Randomized
• Intervention Model: Parallel Assignment
• Masking: None (Open Label)
• Primary Purpose: Treatment
• Official Title: EFFECTS OF RESISTANCE TRAINING ON THE PHYSICAL AND FUNCTIONAL RESPIRATORY PERFORMANCE OF ELDERLY
• Actual Study Start Date: Jan 1, 2017
• Anticipated Primary Completion Date: Dec 1, 2017
• Anticipated Study Completion Date: Jan 1, 2018

Arms and Interventions

Arm	Intervention/Treatment
Active Comparator: ResistanceTraining Group The RT program has the following features: 05 classes performing two weekly sessions; day shift; sessions with maximum duration of 1 (one) hour; 02 series; 08 to 12 repetitions; interval between sets of 01 to 02 minutes; exercises: bench press, seated leg press 45°, pull forward, Earth, rowing standing calf standing, power lifting, abdominal and development.	Other: Resistance training group; Resistive exercises for legs and arms
No Intervention: Non training group sedentary elderly

Outcome Measures

Primary Outcome Measures

1. Physical performance [Change from Baseline at 24 weeks]

   distance traveled on ISWT

Secondary Outcome Measures

1. quality of life [Change from Baseline at 24 weeks]

   quality of life (WHOQOL-old)

2. respiratory muscle strength [Change from Baseline at 24 weeks]

   respiratory pressures

3. Hand grip [Change from Baseline at 24 weeks]

   Hand grip test

Eligibility Criteria

Criteria

• Ages Eligible for Study: 60 Years and Older
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: No

Inclusion Criteria:

• 60 year old or more

• Do not have cardiac or respiratory diseases

• neurological, Musculoskeletal and other diseases preventing the practice of exercises

• not being a smoker; agree to participate in the study and signed an informed consent (IC); in the last six months preceding the evaluation did not have participated in physical activity program with the aim of improving physical performance.

Exclusion Criteria:

• Difficult to complete the tasks

• Acute diseases

• Refuse to continue the program

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

• Daysi Tobelem

Investigators

• Study Chair: Dirceu Costa, PhD, Nove de Julho University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

• Responsible Party: Daysi Tobelem, professor, University of Nove de Julho
• ClinicalTrials.gov Identifier: NCT03320005
• Other Study ID Numbers: Resist protocol
• First Posted: Oct 24, 2017
• Last Update Posted: Oct 24, 2017
• Last Verified: Oct 1, 2017

• Individual Participant Data (IPD) Sharing Statement: No
• Plan to Share IPD: No
• Studies a U.S. FDA-regulated Drug Product: No
• Studies a U.S. FDA-regulated Device Product: No
• Keywords provided by Daysi Tobelem, professor, University of Nove de Julho: respiratory performance; quality of life; physical performance

Study Results

No Results Posted as of Oct 24, 2017